布比卡因加肾上腺素与脂质体布比卡因在微创肺切除术后镇痛的随机试验
这项随机、开放标签研究纳入50例择期微创肺部手术成人患者,比较术中切口及肋间注射布比卡因加肾上腺素(1:200000)与脂质体布比卡因的镇痛效果。主要结局为术后住院期间麻醉药品用量,两组在麻醉药品用量、各时间点疼痛评分、住院时长及并发症方面均无统计学差异。
要点
- 两组术后住院期间麻醉药品用量无统计学差异(36.3 mg 对 38 mg)。
- 术后当日、第1天、第2天、2周及3个月疼痛评分两组相似。
- 作者倾向使用较便宜的非脂质体布比卡因,直至有更多数据。
核心结论
- 在这项小型随机研究中,布比卡因加肾上腺素与脂质体布比卡因在减轻微创肺切除术后疼痛方面未发现显著差异。
- 作者目前倾向于使用较便宜的非脂质体布比卡因制剂,直至获得更多数据。
研究设计与样本
- 随机、开放标签研究(NCT03560362)。
- 纳入50例择期接受微创肺部手术的成人患者,25例接受布比卡因加肾上腺素,25例接受脂质体布比卡因。
- 切口部位在切皮前注射布比卡因加肾上腺素或脂质体布比卡因,进入胸腔时每个肋间注射1 mL布比卡因加肾上腺素或脂质体布比卡因。
- 恢复室开始患者自控镇痛,疼痛采用视觉模拟量表记录。
- 主要结局为术后住院期间麻醉药品用量。
主要发现
- 两组在年龄、组织学和所行手术方面相似。
- 术后住院期间麻醉药品用量无统计学差异(布比卡因组36.3 mg,脂质体布比卡因组38 mg)。
- 疼痛评分:手术当日5和5,术后第1天3.5和2.3,第2天3和2.6,2周0和1,3个月0和0。
- 住院时长和并发症也相似。
临床怎么用
- 对于微创肺切除术患者,可考虑使用较便宜的非脂质体布比卡因加肾上腺素进行术中局部镇痛。
- 在缺乏更多数据前,脂质体布比卡因并未显示出优于布比卡因加肾上腺素的镇痛效果。
局限性
- 样本量小(共50例),随机、开放标签设计。
- 单中心研究,可能影响结果外推。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Thoracic surgery can cause significant pain, and multiple strategies have been developed to control pain after surgery. We compared 2 bupivacaine formulations given intraoperatively: bupivacaine with epinephrine (1,200,000) or liposomal bupivacaine. METHODS: This was a randomized, open-label study (NCT03560362). Eligible patients were adults scheduled for a minimally invasive lung procedure. Incision sites were injected with bupivacaine with epinephrine or liposomal bupivacaine before incision, and each intercostal space was injected with 1 mL of bupivacaine with epinephrine or liposomal bupivacaine entering the thoracic cavity. Patient-controlled analgesia was initiated in the recovery room. Pain was recorded using a visual analog scale. The primary outcome was the amount of narcotics taken during the postoperative hospital stay. RESULTS: We recruited 50 patients; 25 received bupivacaine with epinephrine, and 25 received liposomal bupivacaine. The treatment groups were similar in age, histology, and procedure performed. There were no statistical differences between the treatment groups in the amount of narcotics required during the hospital stay (36.3 mg for bupivacaine and 38 mg for liposomal bupivacaine) or in pain assessed the day of surgery (5 and 5), the first day (3.5 and 2.3), second day (3 and 2.6), 2 weeks (0 and 1), or 3 months (0 and 0) postoperatively. Hospital length of stay and complications were also similar. CONCLUSIONS: In a small, randomized study, we did not find significant differences between bupivacaine with epinephrine or liposomal bupivacaine in mitigating pain after minimally invasive lung resection. We currently favor using the less expensive nonliposomal bupivacaine preparations until additional data are available.
引用
- Weksler B, Sullivan JL, Schumacher LY, et al. Randomized trial of bupivacaine with epinephrine versus bupivacaine liposome suspension in patients undergoing minimally invasive lung resection. J Thorac Cardiovasc Surg. 2020. PMID: 32448693. doi:10.1016/j.jtcvs.2020.01.112
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。